The Pertussis Vaccine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Pertussis Vaccine Market?
The market for the pertussis vaccine has been expanding consistently over the years. The market size will increase from $5.5 billion in 2024 to $5.72 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Pertussis Vaccine Industry?
The market size of the pertussis vaccine is predicted to reach $6.62 billion by 2029, growing at a compound annual growth rate (CAGR) of 3.7%.
Download Your Free Sample of the 2025 Pertussis Vaccine Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Pertussis Vaccine Market?
The key drivers in the pertussis vaccine market are:
• Rising demand for booster vaccinations
• Growing emphasis on maternal immunization
• Increasing immunization requirements among healthcare workers
• Implementation of global health initiatives
Global Market Segmentation: Identifying Major Pertussis Vaccine Industry Segments
The pertussis vaccine market covered in this report is segmented –
1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics
Pre-order the 2025 Pertussis Vaccine Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Pertussis Vaccine Market?
The key trends in the pertussis vaccine market are:
• Personalized immunization schedules are an emerging trend in the Pertussis vaccine market.
• The introduction and development of combination vaccines is influencing the future of the market.
• Vaccination equity initiatives are becoming increasingly prevalent.
• The integration of digital health in immunization is an up-and-coming trend.
Who Are the Top Competitors & Leading Players in the Pertussis Vaccine Market?
Major companies in the pertussis vaccine market are:
• Pfizer Inc.
• Johnson And Johnson Pvt Ltd.
• Merck And Co. Inc.
• Novartis AG
• GlaxoSmithKline PLC
• AstraZeneca PLC
• BioNTech SE
• Moderna Inc.
• Sinovac Biotech Ltd.
• CSL Limited
• Astellas Pharma US Inc.
• Sanofi Pasteur SA
• Mitsubishi Tanabe Pharma America Inc.
• PT Kalbe Farma Tbk
• CSL Seqirus
• Walvax Biotechnology Co.Ltd.
• Biological E. Limited
• Serum Institute of India
• Bavarian Nordic AS
• PT Bio Farma
• Bharat Biotech International Limited
• Takeda Pharmaceutical Company
• Panacea Biotec Limited
• Beijing Minhai Biotechnology Co. Ltd.
• Protein Sciences Corporation
• Wuhan Institute of Biological Products
• Changchun Changsheng Life Sciences
• Changsheng Bio-Technology Co. Ltd.
• Gennova Biopharmaceuticals Ltd.
• Chiron Corporation
Regional Dominance: Which Area Leads the Global Pertussis Vaccine Market?
North America was the largest region in the pertussis vaccine market in 2024
